Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA)

NCT03881059 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

203

Enrollment

INDUSTRY

Sponsor class

Conditions

Active Psoriatic Arthritis

Interventions

OTHER: BMS-986165 Placebo
DRUG: BMS-986165 Dose A
DRUG: BMS-986165 Dose B
DRUG: Ustekinumab
OTHER: Ustekinumab Placebo

Sponsor

Bristol-Myers Squibb